Gelinck, L B S <br/><br/>
The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination.  [electronic resource] 

 -  Annals of the rheumatic diseases  May 2008 
 - 713-6 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1468-2060 
<br/><br/><label>Standard No.: </label>10.1136/ard.2007.077552  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab<br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Antibodies, Viral--blood<br/>Arthritis, Rheumatoid--drug therapy<br/>Autoimmune Diseases--drug therapy<br/>Case-Control Studies<br/>Crohn Disease--drug therapy<br/>Etanercept<br/>Female<br/>Hemagglutination Inhibition Tests<br/>Humans<br/>Immunoglobulin G--therapeutic use<br/>Immunosuppressive Agents--therapeutic use<br/>Infliximab<br/>Influenza A Virus, H3N2 Subtype--immunology<br/>Influenza B virus--immunology<br/>Influenza Vaccines--administration & dosage<br/>Influenza, Human--immunology<br/>Male<br/>Middle Aged<br/>Receptors, Tumor Necrosis Factor--therapeutic use<br/>Time Factors<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors